| A glial signature and Wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment A Griveau, G Seano, SJ Shelton, R Kupp, A Jahangiri, K Obernier, ... Cancer cell 33 (5), 874-889. e7, 2018 | 205 | 2018 |
| Solid stress in brain tumours causes neuronal loss and neurological dysfunction and can be reversed by lithium G Seano, HT Nia, KE Emblem, M Datta, J Ren, S Krishnan, J Kloepper, ... Nature biomedical engineering 3 (3), 230-245, 2019 | 154 | 2019 |
| Targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas Amoozgar Z, Kloepper J, Ren J, Tay RE, Kazer SW, Kiner E, Krishnan S, Posada J Nature Communications 12 (Article number: 2582 (2021)), 2021 | 114 | 2021 |
| Modulation of cerebral endothelial cell function by TGF-β in glioblastoma: VEGF-dependent angiogenesis versus endothelial mesenchymal transition S Krishnan, E Szabo, I Burghardt, K Frei, G Tabatabai, M Weller Oncotarget 6 (26), 22480, 2015 | 62 | 2015 |
| Thymosin beta 4 gene silencing decreases stemness and invasiveness in glioblastoma HG Wirsching, S Krishnan, AM Florea, K Frei, N Krayenbühl, ... Brain 137 (2), 433-448, 2014 | 53 | 2014 |
| Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma mouse models M Datta, S Chatterjee, EM Perez, S Gritsch, S Roberge, M Duquette, ... Proceedings of the National Academy of Sciences 120 (6), e2219199120, 2023 | 17 | 2023 |
| Novel progranulin mutations with reduced serum-progranulin levels in frontotemporal lobar degeneration HH Chiang, C Forsell, L Lilius, L Öijerstedt, S Thordardottir, ... European Journal of Human Genetics 21 (11), 1260-1265, 2013 | 16 | 2013 |
| Pharmacological evaluation of methanolic leaf extract of Swietenia mahagoni on acrylamide-induced neuropathic pain in rats S Vanitha, VRK Thiagarajan, A Muthuraman, S Krishnan, A Aruna, ... Toxicology and Industrial Health 31 (12), 1185-1194, 2015 | 15 | 2015 |
| Combined blockade of VEGF, Angiopoietin-2, and PD1 reprograms glioblastoma endothelial cells into quasi-antigen-presenting cells Z Amoozgar, J Ren, N Wang, P Andersson, GB Ferraro, S Krishnan, ... bioRxiv, 2022.09. 03.506476, 2022 | 5 | 2022 |
| 470 Botensilimab, an Fc-enhanced CTLA-4 antibody, enhances innate and adaptive immune activation to promote superior anti-tumor immunity in cold and IO refractory tumors C Delepine, D Levey, S Krishnan, KS Kim, A Sonabend, M Wilkens, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | 2 | 2022 |
| Implications of a granulocyte-high glioblastoma microenvironment in immune suppression and therapy resistance S Krishnan, Z Amoozgar, F Dai, RK Jain Journal of Pathology 253, 160‐173, 2021 | 2 | 2021 |
| Abstract P057: targeting Treg cells with GITR activation alleviates resistance to immunotherapy in murine glioblastomas Z Amoozgar, J Kloepper, J Ren, RE Tay, SW Kazer, E Kiner, S Krishnan, ... Cancer Immunology Research 10 (1_Supplement), P057-P057, 2022 | 1 | 2022 |
| Antigen presentation deficiency, mesenchymal differentiation, and resistance to immunotherapy in the murine syngeneic CT2A tumor model JB Iorgulescu, N Ruthen, R Ahn, E Panagioti, PC Gokhale, M Neagu, ... Frontiers in immunology 14, 1297932, 2023 | | 2023 |
| 897-F Wnt inhibition improves efficacy of immune checkpoint blockade in glioblastoma S Krishnan, S Lee, Z Amoozgar, S Subudhi, AS Kumar, J Posada, ... Journal for ImmunoTherapy of Cancer 11 (Suppl 2), 2023 | | 2023 |
| Antigen presentation deficiency and mesenchymal differentiation underlie resistance to immunotherapy in the murine syngeneic CT2A tumor model B Iorgulescu, N Ruthen, R Ahn, E Panagioti, P Gokhale, M Neagu, ... Cancer Research 83 (7_Supplement), 2990-2990, 2023 | | 2023 |
| TMIC-61. LOSARTAN PREVENTS IMMUNOTHERAPY-ASSOCIATED EDEMA AND ENHANCES SURVIVAL IN GLIOBLASTOMA M Datta, S Chatterjee, E Perez, S Gritsch, S Roberge, M Duquette, I Chen, ... Neuro-Oncology 24 (Suppl 7), vii285, 2022 | | 2022 |
| 907 Blockade of VEGF, angiopoietin-2, and PD1 reprograms dysfunctional endothelial cells in glioblastoma to quasi-antigen-presenting cells Z Amoozgar, J Ren, N Wang, P Andersson, G Ferraro, S Krishnan, PJ Lei, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| 941 Botensilimab modulates innate and adaptive gene expression programs resulting in superior immune stimulation relative to a first-generation anti-CTLA-4 antibody S Krishnan, J Chow, KT Soh, K Ostergard, C MacDermaid, M Van Dijk, ... Journal for ImmunoTherapy of Cancer 10 (Suppl 2), 2022 | | 2022 |
| Losartan controls immune checkpoint blocker-induced edema and improves survival in glioblastoma M Datta, S Chatterjee, EM Perez, S Gritsch, S Roberge, M Duquette, ... bioRxiv, 2022.06. 28.497997, 2022 | | 2022 |
| OS12. 4 In vivo dynamics and targeting of vessel co-option in glioma G Seano, A Griveau, S Shelton, S Krishnan, N Wang, J Kloepper, ... Neuro-Oncology 21 (Suppl 3), iii23, 2019 | | 2019 |
Hans-Georg WirschingUniversity Hospital and University of ZurichVerified email at usz.ch
